ENDEXX CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0161 USD | -10.56% |
|
+17.52% | -8.00% |
| 2023 | Endexx Corporation Announces the Appointment of Claude Zdanow as Director | CI |
| 2023 | Endexx Corporation Secures Re Order for Non-Nicotine Vape Product HYLA from Italy | CI |
| Sales 2021 | 651K 51.27M | Sales 2022 | 1.28M 101M | Capitalization | 52.31M 4.12B |
|---|---|---|---|---|---|
| Net income 2021 | -6M -473M | Net income 2022 | -4M -315M | EV / Sales 2021 | 47.5 x |
| Net Debt 2021 | 6.87M 542M | Net Debt 2022 | 9.57M 754M | EV / Sales 2022 | 48.4 x |
| P/E ratio 2021 |
-3.45
x | P/E ratio 2022 |
-12.2
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 93.66% |
More Fundamentals
* Assessed data
More press releases
| 1 day | -10.56% | ||
| 1 week | +17.52% | ||
| 1 month | -27.15% | ||
| 3 months | -39.02% | ||
| 6 months | -9.55% | ||
| Current year | -8.00% |
1 week
0.01
0.02
1 month
0.010.02
Current year
0.010.03
1 year
0.010.05
3 years
0.000.15
5 years
0.000.42
10 years
0.000.75
| Managers | Title | Age | Since |
|---|---|---|---|
Todd Davis
CEO | Chief Executive Officer | 55 | 31/12/02 |
Steven M. Plumb
DFI | Director of Finance/CFO | 64 | 30/08/22 |
Ronald Cotting
COO | Chief Operating Officer | - | 31/03/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Todd Davis
CEO | Chief Executive Officer | 55 | 31/12/02 |
Claude Zdanow
BRD | Director/Board Member | 35 | 10-31 |
Dustin Sullivan
BRD | Director/Board Member | 49 | 17/09/18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/06/24 | 0.0161 | -10.56% | 214,375 |
| 17/06/24 | 0.018 | -4.76% | 159,758 |
| 14/06/24 | 0.0189 | -3.08% | 217,726 |
| 13/06/24 | 0.0195 | +42.34% | 626,028 |
| 12/06/24 | 0.0137 | -2.14% | 129,000 |
Delayed Quote OTC Markets, June 18, 2024 at 08:50 pm
More quotes
Endexx Corporation develops hemp-derived, cannabidiol (CBD)-based products, each formulated to address key segments of the health and wellness market. Through its subsidiaries, the Company sells oils, extracts, topicals, and pet products, all with the shared purpose of supporting the therapeutic relief of pain and inflammation for humans and pets through its e-commerce site www.cbdunlimited.com, as well as other online and in-store retailers. In addition to its consumer products, the Company's Gorilla-Tek division offers an automated dispensing system providing a secure method of distributing hemp-based products. The Company also owns and operates a number of subsidiaries that offer technology and consulting solutions to the hemp and hemp-derived product industry, including Seed-to-Shelf compliance and inventory tracking and process management system for regulated products in a front of counter pharmacy support platform.
Sector
Pharmaceuticals
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.00% | 8.15M | |
| -3.27% | 2.89B | |
| +72.26% | 1.61B | |
| +84.13% | 61.6M |
- Stock Market
- Equities
- EDXC Stock
